Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 17Gastrointestinal 11Head & Neck 6Tumor-Agnostic 4Other solid neoplasm 4Genitourinary 4Dermatologic 3Lymphoid 2Gynecologic 2CNS 2Breast 2Sarcoma 1Plasma cell 1

Conditions

Melanoma 3Head and Neck Neoplasms 1

Interventions

pembrolizumab 339Nivolumab 305Ipilimumab 274Cyclophosphamide 195aldesleukin 148Interleukin-2 110fludarabine phosphate 107trametinib 85Temozolomide 83fludarabine 81Dacarbazine 81dabrafenib 77Radiotherapy 75Biopsy 75Vemurafenib 71Imiquimod 53Bevacizumab 51sargramostim 50Magnetic Resonance Spectroscopy 50Radiosurgery 49Peripheral Blood Stem Cell Transplantation 49Paclitaxel 49Aminolevulinic Acid 49binimetinib 48Specimen Handling 48Carboplatin 48Blood Specimen Collection 47cemiplimab 46Cisplatin 453-ingenyl angelate 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Tiragolumab × Dermatologic × Clear all
NCT05116202 2025-07-18

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Melanoma (Morpheus-Melanoma)

Hoffmann-La Roche

Phase 1/2 Completed
110 enrolled 27 charts
Dermatologic

Melanoma

NCT05483400 2025-03-30

TIRACAN

University Medical Center Groningen

Phase 2 Recruiting
97 enrolled
DermatologicHead & Neck

Head and Neck Neoplasms, Melanoma

NCT05060003 2024-02-20

Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection

Washington University School of Medicine

Phase 2 Terminated
7 enrolled 4 charts
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡